Boston Scientific Announces Results For First Quarter 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Boston Scientific (BSX) PT Raised to $26 at Needham & Company
April 27, 2016 2:13 PM EDTNeedham & Company analyst Mike Matson reiterated a Buy rating and boosted his price target on Boston Scientific (NYSE: BSX) to $26.00 (from $22.00), saying Q1 marks and inflection point for growth and margins.
Matson commented, "BSX beat consensus 1Q16 revenue and EPS by a wide margin.... More
Boston Scientific (BSX) Gains Following Strong Results, Outlook
April 27, 2016 9:53 AM EDTBoston Scientific (NYSE: BSX) is strong out of the gate following better-than-expected earnings and a raised outlook. Shares last traded up 8.9%.
Boston Scientific (NYSE: BSX) reported Q1 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the... More
Boston Scientific (BSX) Tops Q1 EPS by 4c; Boosts FY16 Outlook
April 27, 2016 6:32 AM EDTBoston Scientific (NYSE: BSX) reported Q1 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the quarter came in at $1.96 billion versus the consensus estimate of $1.91 billion.
GUIDANCE:
Boston Scientific sees Q2 2016 EPS of $0.25-$0.27, versus the consensus of $0.26.... More
